Interestingly, even though AIM1, ERGIC1, TMED3 and TPX2 were partially expressed in separate subsets of prostate cancers, all of the candidate target genes were found to be regulated by ERG oncogene as well as androgens highlighting the significance of ERG and androgens in promoting prostate oncogenesis. This evidence concerns the gene TMED3 and prostate carcinoma.